MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
4.440
-0.030 (-0.67%)
May 27, 2026, 2:24 PM EDT - Market open
MacroGenics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, MacroGenics stock has a consensus rating of "Buy" and an average price target of $6.75. The average 1-year stock price forecast is 52.03% higher than the current stock price, while the lowest is $4.00 (-9.91%) and the highest is $9.00 (+102.70%).
Price Target: $6.75 (+52.03%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MacroGenics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Nov '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 5 | 5 | 5 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $4 | Hold | Maintains | $4 | -9.91% | May 14, 2026 |
| Barclays | Barclays | Buy Reiterates $6 | Buy | Reiterates | $6 | +35.14% | May 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 7, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Upgrades $9 | Buy | Upgrades | $9 | +102.70% | Apr 10, 2026 |
| TD Cowen | TD Cowen | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 9, 2026 |
Financial Forecast
Revenue This Year
124.60M
from 149.50M
Decreased by -16.66%
Revenue Next Year
81.83M
from 124.60M
Decreased by -34.33%
EPS This Year
-1.17
from -1.18
EPS Next Year
-1.63
from -1.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 228.9M | 159.1M | ||||||
| Avg | 124.6M | 81.8M | ||||||
| Low | 57.8M | 5.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 53.1% | 27.7% | ||||||
| Avg | -16.7% | -34.3% | ||||||
| Low | -61.3% | -95.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.85 | -0.61 | |||
| Avg | -1.17 | -1.63 | |||
| Low | -2.74 | -2.94 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.